Brought to you by 
Incline Therapeutics gets $22mm in Series A money so far; raises additional $21.5mm
07 Oct 2011
Executive Summary
One-year-old hospital-focused specialty pharma company Incline Therapeutics Inc. has raised $22mm through its Series A venture round so far. According to the company's Form D, it may bring in another $21.5mm before closing.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Incline Therapeutics gets $22mm in Series A money so far; raises additional $21.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice